Protein expression profiles in Saccharomyces cerevisiae during apoptosis induced by H2O2. by Magherini, Francesca et al.
RESEARCH ARTICLE
Protein expression profiles in Saccharomyces cerevisiae
during apoptosis induced by H2O2
Francesca Magherini1*, Chiara Tani2*, Tania Gamberi1, Anna Caselli1, Laura Bianchi2,
Luca Bini2 and Alessandra Modesti1
1 Dipartimento di Scienze Biochimiche, Università degli Studi di Firenze, Firenze, Italy
2 Dipartimento di Biologia Molecolare, Università di Siena, Siena, Italy
We identified the proteins involved during apoptosis induced by H2O2 in Saccharomyces cerevisiae,
and analyzed the global protein pattern by 2-DE. We analyzed classical parameters of apoptosis
such as chromatin condensation, DNA fragmentation, and morphology changes of cells. Expo-
sure of yeast cells to nonphysiological doses of peroxides decreases the expression (or increases
degradation) of enzymes involved in protection against oxidative stress. This leads the yeast cells
to a reduction of their antioxidant defense and makes the cells more prone to apoptosis. In our
data the down expression of peroxiredoxin II and GST I, could induce a perturbation of mito-
chondrial function with an alteration of permeability of the membrane leading to the mitochon-
dria-mediated apoptosis. Moreover, we identified a new spot of a classical glycolytic enzyme: the
glyceraldehyde 3-phosphate dehydrogenase during apoptosis. It is known that GAPDH is an ex-
tremely abundant glycolytic enzyme with multiple functions and that its overexpression is evi-
dent during apoptosis induced by a variety of stimuli. Our results confirm that it is a major
intracellular messenger mediating apoptotic death and that this new spot of GAPDH could be an
intracellular sensor of oxidative stress during apoptosis induced by H2O2 in S. cerevisiae.
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1 Introduction
Apoptosis is a highly regulated form of cell death necessary
during normal embryological development and in normal
tissue homeostasis. This process is also important in the
removal of mutated or infected cells and plays a role in
pathogenesis of a variety of human diseases [1]. For many
years apoptosis was assumed to be an exclusive metazoan
process for its altruistic function, but several studies indicate
that a form of programmed cell death, that is similar to
mammalian apoptosis occurs in the unicellular organisms as
bacteria and yeast Saccharomyces cerevisiae and recently there
has been substantial evidence for apoptosis in fission yeast
[2, 3]. Life and death of unicellular organisms belonging to
communities are in some cases comparable to those of mul-
ticellular organisms. The budding yeast S. cerevisiae and the
fission yeast S. pombe have been employed extensively for the
study of a variety of complex pathways including cell divi-
sion, secretion, and signal transduction. The finding of
apoptosis in yeast is an important discovery per se and it dis-
closes the possibility to use this simple organism as the
model for apoptosis death occurring in higher eukaryotes.
Even if the S. cerevisiae genome does not contain any ho-
mologue of mammalian cell death executor genes, the
expression of these mammalian genes, (ced-4, bax) induces
cell death in yeast showing the phenotypic markers of apop-
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tosis such as chromatin condensation and fragmentation,
DNA breakage and exposition of phosphatidylserine. This is
in accordance with the observation of chromatin condensa-
tion and nuclear fragmentation in S. pombe cells dying due to
the expression of Bak [4] or CED-4 [5].
All these findings suggest that yeast contains a cell death
mechanism related to a mammalian counterpart that can be
activated by mammalian regulators. In S. cerevisiae, apopto-
sis can be detected after stimulation with acetic acid [6], H2O2
[7], UV [8] treatment and also during some physiological
processes as aging and response to the a-factor [9, 10]. Madeo
et al. [7] illustrated a central role of ROS in apoptosis in yeast,
showing that the normal process of respiration in mito-
chondria is a major source of ROS and production of ROS is
enhanced when mitochondrial function is disturbed during
apoptosis.
More recently, the identification of an S. cerevisiae cas-
pase-like protein Yca1p [11], Cdc48 [12], and Nma111p the
yeast homologue of Omi/HtrA2 [13], that are involved in the
apoptotic cascade, strengthens the claim that apoptosis
occurs in yeast [14–18]. Other homologues of genes regulator
of mammalian apoptosis have been identified in yeast, such
as the yeast mitochondrial fission factor Fis1p [19] and the
apoptosis-inducing factor Aif1p [20].
In spite of an increasing amount of data about stimuli
that can induce apoptosis in yeast, little is known about the
signaling pathways that are involved in the realization of the
programmed cell death. Since the elements of the pathways
are conserved in yeast as well as in mammals, yeast should
be useful as a model to study these different pathways. The
aim of the present study is to investigate the S. cerevisiae
proteome during apoptosis induced by H2O2, in order to
identify which pathways are more affected during this pro-
cess. Since H2O2 was demonstrated to induce apoptosis in
mammals as well as in yeast, we choose this kind of stimulus
in order to obtain information about the proteins involved,
useful to understand the apoptotic mechanism in higher
eukaryotes. In this work we used a proteomic approach
based on 2-DE and computer analysis to assess changes in
patterns of yeast cells, combined with MS to identify inter-
esting proteins.
2 Materials and methods
2.1 Yeast strain and growth conditions
The strain used in this study is W303-A (MATa leu2-3,
112ura3-1 trp1-92 his3-11, 15 ade2-1 can1-100, GAL SUC
mal). Yeast cells were grown at 307C in YEPD medium (1%
yeast extract and 2% peptone and 2% w/v glucose used as
carbon source). Solid media contained 2% w/v agar. To
induce apoptosis, H2O2 was added to a final concentration of
3 mM to W303 cells exponentially growing (0.6–0.8 OD/mL)
in YEPD and cells were collected after 3 h.
2.2 Cell viability assay
Cell viability was measured by plating serial dilution of
treated and untreated cells on YEPD plates. The percentage
of colony-forming units (c.f.u.) of treated cells was obtained
by relating the c.f.u. counts of treated cells to those untreated
which were considered to be 100%.
A trypan blue (Sigma, 0.4% solution, cat. T-8154) exclu-
sion assay was adopted to assess cell viability during H2O2
treatment. Cells were washed with distilled water and
stained with 0.01% trypan blue in water for 1 h. At least 200
cells from each sample were examined under the microscope
to determine the proportion of stained cells.
2.3 Apoptotic markers
After 3 h of incubation with H2O2, apoptotic phenotype was
controlled with TUNEL assay using the Roche Diagnostic In
Situ Cell Death Detection Kit Peroxidase. Briefly, yeast cells
were fixed for 1 h with 3.7% formaldehyde. The cell wall was
digested with Lyticase (Sigma) and cells were applied to a
polylysine-coated microscope slides. The slides were rinsed
with PBS, incubated in blocking solution (3% H2O2 in
methanol) and then in permeabilization solution (0.1% Tri-
ton X-100, 0.1% sodium citrate) on ice for 2 min. The slides
were rinsed twice with PBS and incubated with 20 mL of
TUNEL reaction mixture (18 mL TUNEL label containing
fluorescein-dUTP, 2 mLTUNEL enzyme) for 1 h at 377C in a
humid chamber in the dark. Slides were washed three times
in PBS, and incubated with 50 mL of converted-POD and
DAB substrate (Roche) precipitation was visualized under
light microscope.
2.4 Preparation of yeast cell extracts by 2-DE
For 2-DE, apoptotic and control cells were harvested by cen-
trifugation at room temperature. The pellet was washed
twice in water and resuspended in 8 M urea, 4% CHAPS,
and 10 mM DTT. Cells were broken with glass beads in a
Fastprep instrument (Savant) and protein extracts were clar-
ified by centrifugation at 80006g for 10 min. For each
experimental condition at least three samples were run in
order to assess biological and analytical variation. IEF (first
dimension) was carried out on nonlinear wide-range IPGs
(pH 3–10; 18 cm long IPG strips; GE Healthcare, Uppsala,
Sweden) and achieved using the Ettan™ IPGphor™ system
(GE Healthcare). Analytical-run IPG-strips were rehydrated
with 60 mg of total proteins in 350 mL of lysis buffer and 0.2%
v/v carrier ampholyte for 1 h at 0 V and for 8 h at 30 V, at
167C. The strips were then focused according to the follow-
ing electrical conditions at 167C: 200 V for 1 h, from 300 to
3500 V in 30 min, 3500 V for 3 h, from 3500 to 8000 V in
30 min, 8000 V until a total of 80 000 V?h was reached. MS-
preparative IPG-strips were instead rehydrated with 350 mL
of lysis buffer and 2% v/v carrier ampholyte, for 12 h at room
temperature. Sample load, 800 mg per strip, was successively
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performed by cup loading in the IPGphor Cup Loading Strip
Holders (GE Healthcare), and, to obtain a successful focus-
ing on basic pH values, it was applied at the anodic end of the
strip. IEF was then achieved according to the following volt-
age steps, at 167C: 30 V for 30 min, 200 V for 2 h, 500 V for
2 h, from 500 to 3500 V in 30 min, 3500 V for 5 h, from 3500
to 5000 V in 30 min, 5000 V for 4 h, from 5000 to 8000 V in
30 min, 8000 V until a total of 95 000 V?h was reached. After
focusing, analytical and preparative IPG strips were equili-
brated for 12 min in 6 M urea, 30% v/v glycerol, 2% w/v
SDS, 0.05 M Tris-HCl, pH 6.8, 2%w/v DTE, and subse-
quently for 5 min in the same urea/SDS/Tris buffer solution
but substituting the 2% w/v DTE with 2.5% w/v iodoaceta-
mide. The second dimension was carried out on 9–16%
polyacrylamide linear gradient gels (18620 cm 61.5 mm)
at 40 mA/gel constant current and 107C until the dye front
reached the bottom of the gel, according to Laemmli [21] and
Hochstrasser et al. [22]. Analytical gels were stained with
ammoniacal silver nitrate as previously described [23]; while
MS-preparative gels were stained according to a silver stain-
ing protocol compatible with MS [24]. Stained gels were
digitalized using a Molecular Dynamics 300S laser densi-
tometer (400065000 pixels, 12 bits/pixel; Sunnyvale, CA,
USA).
2.5 Image analysis and statistics
For each strain condition namely control and apoptotic yeast
cells, 2-D gels were run in triplicate and only spots present in
all the replicates were taken into consideration for sub-
sequent analysis. Computer-aided 2-D image analysis was
carried out using the MELANIE 4.0 software (GeneBio, Ge-
neva, Switzerland). Relative spot volumes (%V) (V = integra-
tion of OD over the spot area; %V = V single spot/V total
spots) were used for quantitative analysis in order to decrease
experimental errors. The normalized intensity of spots on
three replicate 2-D gels was averaged and SD was calculated
for each condition. A two-tiled nonpaired Student’s t-test was
performed using ORIGIN 6.0 (Microcal Software) to deter-
mine if the relative change was statistically significant.
Reported pI and Mr (Da) values were experimentally deter-
mined by comigration with human serum as the internal
standard [25]. CV was calculated as the SD expressed as a
percentage of the mean.
2.6 Protein identification by MS
Protein identification was carried out by PMF on an Ettan
MALDI-TOF Pro mass spectrometer (Amersham Bio-
sciences), as previously described in Refs. [26, 27]. Electro-
phoretic spots, visualized by MS-compatible silver staining
protocol, were manually excised, destained [28], and ACN
dehydratated. Successively, they were rehydratated in trypsin
solution, and in-gel protein digestion was performed by an
overnight incubation at 377C. From each excised spot,
0.75 mL of recovered digested peptides were prepared for
MALDI-TOF MS by spotting them onto the MALDI target,
allowed to dry, and then mixed with 0.75 mL of matrix solu-
tion (saturated solution of CHCA in 50% v/v ACN and 0.5%
v/v TFA). After matrix application to the dried sample and its
own drying, tryptic peptide masses were acquired. Mass fin-
gerprinting search was carried out in NCBInr and Swiss-Prot
databases using ProFound (http://129.85.19.192/profound_
bin/WebProFound.exe), PeptIdent (http://www.expasy.org),
and MASCOT (Matrix Science, London, UK, http://
www.matrixscience.com) on-line-available softwares. Protein
identification was achieved on the basis of corresponding
experimental and theoretical peptide-fingerprinting pat-
terns, using a peptide mass tolerance of 50 ppm, carbamyla-
tion modification of cysteine residues and allowing a single
missed tryptic cleavage.
Tryptic digests that did not produce MALDI-TOF unam-
biguous identifications were subsequently acidified with
2 mL of a 1% TFA solution, and then subjected to ESI-IT MS/
MS peptide-sequencing on a nanospray/LCQ DECA ITmass
spectrometer (Thermo Finnigan, San Jose, CA, USA). Using
the ZIP-TIP™ pipette tips for sample preparation (Millipore,
Billerica, MA, USA), previously equilibrated in 50% ACN
solution and abundantly washed in 0.1% TFA, acidified
samples were enriched. Tryptic peptide elution from the ZIP-
TIP™ matrix was achieved with a 70% methanol and 0.5%
formic acid solution, and 3 mL of such concentrated sample
solutions were then loaded in the nanospray needle. MS/MS
database searching was performed by TurboSEQUEST
(Thermo) and MASCOT MS/MS ion search software (http://
www.matrixscience.com).
2.7 Western blot
After induction of apoptosis, 100 mg of protein extracts from
control and apoptotic yeast cells were separated by 2-DE as
previously described and transferred on PVDF membrane
(Millipore). The blots were incubated with rabbit polyclonal
GAPDH-HRP-conjugated antibodies (Abcam) in blocking
buffer (PBS, 2% nonfat dry milk, 0.1% v/v Tween-20). The
chemiluminescence immunodetection system (GE Health-
care) was used for signal development.
3 Results
3.1 Effect of H2O2 on apoptosis in S. cerevisiae W303
Previous reports from other authors [7] indicate that incuba-
tion of yeast cells with H2O2 3 mM for 200 min causes sig-
nificant cell death by the induction of apoptosis. Before
starting the differential proteome analysis which is the main
purpose of this work, we wanted to obtain information about
the time and H2O2 concentration-dependence study to
induce apoptotic death in yeast cell strain W303. We used
3 mM H2O2 to induce apoptosis in exponentially growing
yeast cells in complete medium compared with the control.
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As shown in the Fig. 1A the percentage of survival, estimated
by c.f.u. counts, decreases with time. At this concentration
and after 3 h a loss of viability in about 90% of yeast cells
evaluated by colony formation is evident; this is probably due
to the high DNA damages accumulated that make cell repli-
cation impossible. Viability was also evaluated by trypan blue
exclusion, a rapid and simple assay developed for the detec-
tion of dead cells. The method is based on the assumption
that dead cells have nonfunctional membranes, through
which the stain penetrates quickly, whereas living cells
exclude the dye. Thus, dead cells stain, living cells remain
colorless. Our results show that after 3 h of treatment with
3 mM H2O2, cells are not permeable to dye, this means that
probably the cells retain some metabolic activities that per-
mit them to exclude the dye (data not shown). All these data
suggest that an apoptotic process could be the predominant
cell death mechanism in treated cells. The apoptotic pheno-
type was then confirmed by TUNEL assay. After 3 h of treat-
ment with 3 mM H2O2, about 80% of the cells show DNA
cleavage as revealed in Fig. 1C. The arrows show some cells
with TUNEL positive phenotype indicating the nuclear frag-
mentation with an occurrence of DNA strand breaks, in the
treated cells (Fig. 1C) in comparison to the control (Fig. 1B).
3.2 Proteomic analysis
To investigate the S. cerevisiae protein expression during
apoptosis, a comparative proteome analysis was performed
using W303 cells treated with 3 mM H2O2, in comparison to
nontreated cells. After 3 h, proteins were extracted, resolved
by 2-D SDS-PAGE and the resulting silver stained electro-
pherograms were analyzed using the MELANIE 4.0 software.
In Fig. 2, typical 2-DE images of soluble yeast proteins from
Figure 1. Apoptotic phenotype
of H2O2 treated yeast cells. (A)
Relative survival (% of c.f.u. on
YEDP agar plates; 100% corre-
sponds to the number of c.f.u. at
time 0) of S. cerevisiae incu-
bated with 3 mM H2O2 for
180 min. Vertical bars represent
SD. TUNEL reaction to detect
apoptotic phenotype. (B) Con-
trol strain; (C) S. cerevisiae after
180 min of treatment with 3 mM
H2O2. Arrows indicate nuclear
fragmentation.
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control (panel A) and apoptotic cells (panel B) are shown.
The pattern and relative abundance of proteins displayed
correspond well with yeast 2-D protein profile produced pre-
viously in our laboratory [29]. An average of about 2000 spots
were detected in each 2-D gel stained with silver. The quan-
titative and qualitative analyses were performed in triplicate
and an expression change was considered significant if the
intensity of corresponding spot differed reproducibly more
than two-fold in relative volume (%V) between the two types
of yeast cells and was statistically significant. This general
pattern was conserved between replicate gels indicating the
high degree of reproducibility of sample preparation and 2-D
procedures. The computer analysis pointed out 102 quanti-
tative variations between control and apoptotic cells (Fig. 2,
green circles), while 51 (Fig. 2, blue circles) and 46 (Fig. 2,
red circles) spots were exclusively detected in control or
apoptotic cells, respectively. Identification of interesting pro-
teins was carried out by MALDI-TOF MS and ESI-IT MS.
Overall the results reported here indicate that induction of
apoptotic death using H2O2, causes a significant alteration of
protein expression profile in comparison to the untreated
yeast cells.
3.3 Identification of differentially expressed proteins
Among the differentially expressed proteins a total of 31
spots were successfully identified by MS analysis selected on
the basis of their relative abundance, high variation, and
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Figure 2. 2-DE silver-stained gels of total protein extract from control and H2O2 apoptotic cells. Quantitative variations between control
(panel A) and apoptotic yeast cells (panel B) are displayed by green circles. Numbers identify proteins that are present in both gels but
display a different expression level. Blue circles and red circles represent spots present exclusively in control and apoptotic cells, respec-
tively. Small (control cells) and capital (apoptotic cells) letters indicate the identified proteins. Areas highlighted by the box illustrate the
Western blot analysis identifying the new spot (F) of GAPDH present in the apoptotic yeast cells and absent in control cells.
resolution on preparative gels. The locations of these spots
were marked with numbers in representative gels shown in
Fig. 2 (panels A and B). For protein spots with low MASCOT
score (spots 19, 22, and 28), ESI-IT MS/MS peptide-se-
quencing was performed to confirm protein identification.
The identified proteins belonging to this category are de-
scribed and their relative amounts are reported in Table 1.
Twenty-one protein spot volumes change significantly at the
99% confidence level (p,0.01), one protein spot volume
(spot number 28) changes significantly at the 98% con-
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fidence level (p,0.02), six protein spot volumes (spots 4, 7,
12, 17, 24, and 26) change significantly at the 95% confidence
level (p,0.05), while three protein spot volumes (spots 8, 15,
and 23) show a relative change in expression significant at
the 90% confidence level (p,0.1). The average CV of the dif-
ferentially expressed spots is 22 and 24% for gels from con-
trol and apoptotic cells respectively indicating a typical
variability according to Molloy et al. [30]. According to their
biological activity, the proteins are sorted in different func-
tional groups and their relative expression changes are
reported in Fig. 3.
As shown in Table 1 and in corresponding Fig. 3, the
comparative analysis revealed that apoptosis induces a down-
regulation of the expression levels of a large number of the
yeast proteins. The expression levels decrease in three pro-
tein spots as the apoptotic phenotype appears. The expres-
sion level of enolase (spots 6 and 9) and GAPDH (spot 18)
falls as apoptosis proceeds. The down-regulation of these
proteins is thought to reflect growth arrest which occurs to
save energy to induce apoptotic phenotype. The presence of
several protein fragments indicates that protein pattern var-
iation associated to apoptosis induced by H2O2, involves an
activation of proteolysis with the degradation of several pro-
teins. Spots 23, 25, and 29 corresponding to fragments of
enolase appear to increase significantly. Other spots showing
increased abundance included spots 26–28 corresponding to
fragment of GAPDH isoenzymes 2 and 3. These increases
could be due to an enhanced rate of degradation of specific
proteins during apoptosis, which can reflect the loss of pro-
tein function.
Figure 3. Relative protein expression changes of apoptotic vs. control cells. Relative expression changes of proteins that are affected by
3 mM H2O2. White bars (apoptotic cells) and black bars (control cells) represent the mean 6 SD of computer volume percentage from three
different control and apoptotic gels. %V (61024) is calculated as: V single spot/V total spots (V = integration of OD over the spot area).
Proteins are grouped into five different categories: fermentative pathway, glycolysis, amino acids and pyrimidine metabolism, heat shock
proteins, and others.
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Table 1. Relative changes in protein expression in control vs. apoptotic cells
Spot
no.
Protein name ACa) Theore-
ticalb)
pI/Mr (kDa)
Experi-
mentalc)
pI/Mr (kDa)
d) No. of
matched
peptidese)
Sequence
coveragef)
(%)
%V (61024) mean (6SD)g) p valueh)
(61025)
Foldi)
change
c/aControl Apoptosis
1 Transketolase 1 P23254 6.5/73.67 6.7/54.02 71 8 15 321 6 13 62 6 14 3.28 5.2
2 Transketolase 1 P23254 6.5/73.67 6.6/53.34 150 12 21 731 6 86 136 6 23 32.6 5.4
3 Pyruvate decarboxylase 1 P06169 5.8/61.36 6.3/50.38 191 13 38 128 6 25 33 6 6 276 3.9
4 Pyruvate decarboxylase 1
(fragment)
P06169 5.8/61.36 6.3/47.74 154 13 31 160 6 65 39 6 13 3396 4.1
5 Homocitrate synthase cytosolic
isozyme
P48570 6.84/47.10 7.0/47.42 160 12 35 344 6 64 55 6 20 178 6.3
6 Enolase 2 P00925 5.67/46.78 5.9/45.99 114 9 24 1824 6 141 560 6 40 11.9 3.3
7 Heat shock protein 75 (fragment) P11484 5.32/66.47 5.6/45.71 107 11 24 693 6 255 204 6 149 4534 3.4
8 Heat shock protein 75 (fragment) P11484 5.32/66.47 5.7/45.61 183 15 36 359 6 184 99 6 74 8633 3.6
9 Enolase 2 P00925 5.67/46.78 6.0/45.52 162 13 46 3405 6 190 882 6 46 2.38 3.9
10 Pyruvate kinase 1 (fragment) P00549 7.56/54.54 6.6/41.35 88 9 26 2651 6 456 793 6 168 270 3.3
11 Enolase 2 P00925 5.67/46.78 6.2/40.37 147 10 29 964 6 139 210 6 33 79.6 4.6
12 Protein SCP160 (fragment) P06105 5.64/134.81 5.8/39.19 62 9 9 1145 6 420 334 6 87 3050 3.4
13 Fructose-bisphosphate aldolase P14540 5.51/39.49 6.2/38.82 102 9 38 253 6 16 41 6 5 2.89 6.2
14 Pyruvate decarboxylase 1
(fragment)
P06169 5.8/61.36 6.4/38.33 133 12 33 604 6 135 149 6 47 530 4
15 3-Isopropylmalate dehydratase
(fragment)
P07264 5.61/85.79 4.8/37.72 61 6 10 366 6 206 92 6 51 8953 3.9
16 Dihydroorotase P20051 6.07/40.313 6.6/34.75 162 7 24 450 6 27 78 6 14 2.34 5.8
17 Enolase 2 P00925 5.67/46.78 5.9/34.11 138 12 36 464 6 101 232 6 44 2248 2
18 Glyceraldehyde 3-phosphate-
dehydrogenase 3
P00359 6.49/35.61 7.3/32.62 96 8 33 1447 6 44 221 6 64 1.06 6.5
19 Mannose-1-phosphate
guanyltransferase
P41940 5.95/39.56 6.2/29.77 ETFPILVEEKj) 537 6 104 157 6 36 404 3.4
20 Cytocrome c oxidase polypeptide IV P04037 5.10/14.17 4.8/15.52 91 6 55 2869 6 224 282 6 26 3.8 10
21 HNT1 Q04344 6.44/17.68 6.9/13.53 82 6 51 331 6 34 101 6 25 73.1 3.3
22 Heat shock protein SSA2 (fragment) P10592 4.95/69.34 6.7/12.45 DAGTIAGLNVLRj) 2053 6 364 699 6 172 436 2.9
23 Enolase 2 (fragment) P00925 5.67/46.78 5.5/30.62 110 13 33 275 6 49 582 6 195 6066 0.5
24 Triosephosphate isomerase P00942 5.75/26.66 6.3/27.24 128 10 51 1035 6 694 2262 6 270 4682 0.5
25 Enolase 2 (fragment) P00925 5.67/46.78 5.9/26.97 132 11 33 294 6 127 1290 6 110 10 0.2
26 Glyceraldehyde 3-phosphate
dehydrogenase 2-3 (fragment)
P00358-9 6.49/35.71
6.49/35.61
6.5/23.19 68 6 23 357 6 51 1269 6 425 2099 0.3
27 Glyceraldehyde 3-phosphate
dehydrogenase 3 (fragment)
P00359 6.49/35.61 7.0/16.15 86 8 32 189 6 28 1050 6 135 39.5 0.2
28 Glyceraldehyde 3-phosphate
dehydrogenase 2-3 (fragment)
P00358-9 6.49/35.61 7.0/14.66 VAINGFGRj)
VLPELQGKj)
149 6 32 331 6 65 1229 0.5
29 Enolase 2 (fragment) P00925 5.67/46.78 6.1/14.42 72 7 17 159 6 52 3037 6 50 0.02 0.05
30 Homoserine dehydrogenase
(fragment)
P31116 6.86/38.50 6.4/13.77 94 7 22 299 6 78 696 6 99 555 0.4
31 Alcohol dehydrogenase I
(fragment)
P00330 6.26/36.69 6.5/12.59 65 6 23 322 6 31 951 6 94 34.6 0.3
a) Swiss-Prot/TrEMBL accession number.
b) Predicted pI and Mr according to protein sequence.
c) pI and Mr values were experimentally determined using human serum as internal standard.
d) MASCOTscore (Matrix Science, London, UK; http://www.matrixscience.com).
e) Number of peptide masses matching the top hit from Ms-Fit PMF.
f) Percentage of amino acid sequence coverage of matched peptides in the identified proteins.
g) Each value represents the mean 6 SD of individually computed %V (V = integration of OD over the spot area; %V = V single spot/V total
spots) in three different gels of control and apoptotic cells.
h) A Student’s t-test was performed to determine if the relative change was statistically significant.
i) Fold change (control vs. apoptosis) was calculated dividing %V from control by the %V from apoptotic gels.
j) Sequence tag identified by ESI-IT MS/MS peptide-sequencing.
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3.4 Proteins exclusively detected in control yeast
cells
Thirteen out of these 51 proteins, whose expression resulted
in inhibition during the apoptotic process, were successfully
identified (Table 2). The locations of these 13 protein spots
are marked with small letters in the representative gel shown
in Fig. 2A. In Fig. 4, are shown two examples of spots corre-
sponding to proteins which disappear during apoptosis: per-
oxiredoxin (Prx) II and eukaryotic translation factor 4B.
Some of these proteins (spots h and i, respectively), are
related to the cellular antioxidant defense and comprise a
protein involved in the pathways for detoxification, the GST I
and an antioxidant enzyme reducing hydroperoxides, the Prx
II. This contains a conserved Cys residue that undergoes a
cycle of peroxide-dependent oxidation and thiol-dependent
reduction during catalysis. GST I has been shown to reacti-
vate oxidized Cys of Prx. GST are ubiquitous in nature and
this suggests their functions in living systems in addition to
detoxification [31]. Recently, it has been demonstrated the
formation of a dimer between GSTwith a Cys of Prx has been
demonstrated. It has been hypothesized that Prx might be
essential in protection of cells against apoptosis induced by a
variety of stress-inducing agents [32]. Moreover, it has been
found that Prx are essential proteins required for appropriate
mitochondrial function. Of the 13 identified proteins one is
involved directly in glycolysis: the fructose-bisphosphate
aldolase, spot g. Others, identified as fragments, are involved
in the fermentative pathway and in amino acid metabolism.
3.5 Proteins exclusively detected in apoptotic yeast
cells
The identity of 11 of the 46 proteins induced during apoptosis
is reported in Table 3. The locations of these 11 identified pro-
teins are marked with capital letters in the representative gel
shown in Fig. 2B. Many of the new spots induced by apoptosis
and present only in the treated cells, belong to new fragments
of several proteins (spots B and C both identified as fragments
of phosphoglycerate kinase). It is interesting to observe that a
glycolytic enzyme, theGAPDHisoform3 (spotF), is present in
the apoptotic cells as a new spot in the 2-D gel (Fig. 2) this new
spot is shown in the enlargement in Fig. 4. The Figure shows
another typical example of protein spot in which expression
level is detectable only in apoptotic cells, the enolase isoform 2
(fragment). The glyceraldehyde-3-phosphate dehydrogenase
is a classical glycolytic enzyme and is a multifunctional pro-
tein. The biological significance of this new migration is still
unclear but it could be due to potential modifications of the
protein occurring during apoptosis induced by H2O2. More-
over, many groups reported that GAPDH translocates to the
nucleus under oxidative stressors [33].
Table 2. Identification of proteins exclusively detected in control yeast cells
Spot Protein name ACa) Theoreticalb)
pI/Mr (kDa)
Experimentalc)
pI/Mr (kDa)
d) No. of matched
peptidese)
Sequence
coveragef)
(%)
a Eukaryotic translation initiation factor 4B
(eIF-4B)
P34167 5.17/48.52 5.1/74.33 104 8 22
b Aminopeptidase Y P37302 5.37/53.9 5.9/61.76 FGFTAVVIYDNEPKg)
c Seryl-tRNA synthetase cytoplasmic P07284 5.8/53.31 6.4/53.17 ELVSCSNCTDYQSRg)
d Transketolase 1 (fragment) P23254 6.5/73.67 6.9/45.52 64 9 14
e Pyruvate decarboxylase 1 (fragment) P06169 5.8/61.36 5.6/32.40 107 10 26
f Heat shock protein 60 (fragment) P19882 4.9/57.82 6.0/31.64 103 9 18
g Fructose bisphosphatealdolase P14540 5.51/39.49 5.1/28.48 64 7 31
h GST I P40582 6.18/26.79 6.5/25.82 106 7 35
i Prx type II P38013 5.01/18.98 5.0/20.08 126 9 68
j Glyceraldehyde 3-phosphate
dehydrogenase 2
P00358 6.49/35.71 6.8/17.74 VLPELOGKg)
k Phosphoglycerate kinase (fragment) P00560 7.09/44.61 6.3/16.76 70 6 17
l Phosphoglycerate kinase (fragment) P00560 7.09/44.61 6.6/16.16 75 6 22
m 60S ribosomal protein L27 P38706 15.53/10.36 6.2/14.52 1) NQWFFSKg)
2) VVNYNHLLTRg)
a) SwissProt/TrEMBL accession number.
b) Predicted pI and Mr according to protein sequence.
c) pI and Mr values were experimentally determined using human serum as internal standard.
d) MASCOTscore (Matrix Science, London, UK; http://www.matrixscience.com)
e) Number of peptide masses matching the top hit from Ms-Fit PMF.
f) Percentage of amino acid sequence coverage of matched peptides in the identified proteins.
g) Sequence tag identified by ESI-IT MS/MS peptide-sequencing.
© 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Proteomics 2007, 7, 1434–1445 Microbiology 1443
Figure 4. Magnified regions of triplicate 2-D gel images of proteins only detected in control or in apoptotic cells. Protein spots of interest
are indicated with circles, with the corresponding protein names pointed out on the left. Gel segments shown in this figure were enlarged
from Fig. 2. Histograms show the protein abundance, with protein intensity of the 2-D gels indicated in gray and white, for control and
apoptotic cells, respectively.
Table 3. Identification of proteins exclusively detected in apoptotic yeast cells.
Spot Protein name ACa) Theoreticalb)
pI/Mr (kDa)
Experimentalc)
pI/Mr (kDa)
d) No. of matched
peptidese)
Sequence
coveragef)
(%)
A Transketolase 1 (fragment) P23254 6.5/73.67 6.6/43.77 EALDFQPPSSGSGNYSGRg)
B Phosphoglycerate kinase (fragment) P00560 7.09/44.61 6.6/33.13 117 8 25
C Phosphoglycerate kinase (fragment) P00560 7.09/44.61 6.7/31.99 108 7 22
D Protein SCP160 (fragment) P06105 5.64/134.80 6.6/31.25 88 8 7
E Enolase 2 (fragment) P00925 5.67/46.78 6.7/30.17 83 8 19
F Glyceraldehyde 3-phosphate
dehydrogenase 3
P00359 6.49/35.61 6.6/29.82 123 11 40
G Enolase 2 (fragment) P00925 5.67/46.78 6.1/26.43 85 7 20
H Elongation factor 1 2 a (fragment) P02994 9.03/50.14 7.0/24.22 81 6 21
I Triosephosphate isomerase P00942 5.75/26.67 6.2/22.42 137 8 39
J Heat shock protein SSA2 (fragment) P10592 4.95/69.34 6.3/22.06 93 9 18
K Enolase 2 (fragment) P00925 5.67/46.78 7.0/14.13 75 6 15
a) Swiss-Prot/TrEMBL accession number.
b) Predicted pI and Mr according to protein sequence.
c) pI and Mr values were experimentally determined using human serum as internal standard.
d) MASCOTscore (Matrix Science, London, UK; http://www.matrixscience.com).
e) Number of peptide masses matching the top hit from Ms-Fit PMF.
f) Percentage of amino acid sequence coverage of matched peptides in the identified proteins.
g) Sequence tag identified by ESI-IT MS/MS peptide sequencing.
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3.6 Western-blot analysis of GAPDH protein
expression in H2O2 apoptotic cells
In order to validate the results discussed above in which we
identify by 2-D and MS a new spot corresponding to a
GAPDH isoform (spot F in Fig. 2B), we analyzed the proteins
extracted from apoptotic or nonapoptotic cells by Western
blotting with anti-GAPDH antibodies. Our results reveal that
the new GAPDH isoform present in apoptotic cells (Fig. 2
WB) is not visible in the Western blot from the control cells.
The results shown in the 2-D Western blotting of GAPDH
are consistent with the results from 2-DE and MS-based
identification. The new spot F, corresponding to GAPDH
isoform by MS identification, is evident in the immunoblots
derived from extracts of apoptotic and nonapoptotic cells
(Supporting Information Fig. 1).
4 Discussion
The yeast model could help to understand the complicated
hierarchy between different apoptotic pathways and be able
to elucidate the protein pathways involved in apoptosis. In
this study, we investigated the changes in the proteome of
yeast S. cerevisiae to identify proteins that are implicated in
apoptosis induced by H2O2 and we verified that this treat-
ment induces many changes in the expression level of pro-
teins involved in metabolism, stress response, and oxidant
protection.
A general down regulation of expression level of
enzymes involved in glycolysis, fermentation, and other
metabolic functions is observed. Since after H2O2 treatment
the cells stop dividing, the global decrease in protein expres-
sion verified with proteome analysis, could be attributed to a
general inhibition of protein synthesis and/or an increase in
protein degradation. Protein synthesis could be impaired
since some proteins involved in this process are detectable
only in control cells and on the other hand, during apoptosis
there is an increase in several fragments of metabolic
enzymes that could be the result of a partial degradation. We
identified two proteins in which the expression is dramati-
cally reduced in the apoptotic cells: the GST I and Prx II.
These are implicated in protection against oxidative stress,
and are potentially involved as antiapoptotic proteins [34].
Hydrogen peroxide and other ROS, play a role key in a variety
of biological processes but can damage nucleic acids, pro-
teins, and lipids. Therefore, specific cell antioxidant systems
are essential to control the intracellular level of ROS. These
systems include reducing agents like glutathione and thio-
redoxin. Prx reduce hydrogen peroxide by electron transfer
from thioredoxins, glutathione, or cyclophilins. Moreover, in
the cells the reduction pathway involves glutathione and
GST. In our results, exposure of yeast cells to non-
physiological doses of peroxides, significantly decreases the
abundance of these enzymes. All these data suggest that
H2O2 treatment decreases the expression (or increases deg-
radation) of these enzymes leading the yeast cells to a reduc-
tion of their antioxidant defense and a down regulation of the
expression of these proteins makes the yeast cells more
prone to apoptosis. It has been recently shown that adapta-
tion of cells to H2O2 is in part due to the redirection of car-
bohydrate flux from glycolysis to the pentose phosphate
pathway to the regeneration of NADPH responsible for the
maintenance of both Prx and glutathione in their reduced
states [35]. It is well known that, in mammalian cells, Prx are
involved in the regulation of several mitochondrial processes
such as an alteration of mitochondrial structure. In our data
the down expression of Prx II during H2O2 treatment, could
induce a perturbation of mitochondrial function bringing
about an alteration of permeability of the membrane leading
to the mitochondria-mediated apoptosis. Numerous studies
demonstrated that survival and cell death are linked to glu-
cose metabolism [33] and that apoptosis is partly dependent
on energy status. In our results it is interesting to note that
two glycolytic enzymes increase their expression level in
comparison to the control: triosephosphate isomease and
GAPDH (isoform 3). Since these enzymes work in sequence
during glycolysis, it is possible to suggest a maintenance of
glycolysis for the production of energy within cells. In par-
ticular, we can observe a new spot of GAPDH isoform 3 in
the proteome from apoptotic yeast cells. GAPDH is an ex-
tremely abundant glycolytic enzyme with multiple and see-
mingly unrelated functions. Recent studies demonstrated
that GAPDH expression was increased during apoptosis
induced by a variety of factors including nutrient starvation,
prolonged culture, and cytotoxic agent treatment [36]. In
conclusion our results suggest that this new spot of GAPDH
could be an intracellular sensor of oxidative stress during
apoptosis induced by H2O2 in S. cerevisiae.
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